Chromadex Historical Income Statement

CDXC Stock  USD 7.59  0.13  1.74%   
Historical analysis of Chromadex Corp income statement accounts such as Interest Expense of 3.3 K, Selling General Administrative of 16.5 M or Total Revenue of 87.7 M can show how well Chromadex Corp performed in making a profits. Evaluating Chromadex Corp income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Chromadex Corp's future profits or losses.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Chromadex Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chromadex Corp is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.

About Chromadex Income Statement Analysis

Chromadex Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Chromadex Corp shareholders. The income statement also shows Chromadex investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Chromadex Corp Income Statement Chart

At present, Chromadex Corp's Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 93.6 M, whereas Depreciation And Amortization is forecasted to decline to about 863.7 K.

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Total Revenue

Total revenue comprises all receipts Chromadex Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.
Most accounts from Chromadex Corp's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Chromadex Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.At present, Chromadex Corp's Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Other Operating Expenses is expected to grow to about 93.6 M, whereas Depreciation And Amortization is forecasted to decline to about 863.7 K.
 2021 2022 2023 2024 (projected)
Interest Expense55K3K3.5K3.3K
Depreciation And Amortization1.6M1.9M1.7M863.7K

Chromadex Corp income statement Correlations

-0.020.90.830.840.9-0.6-0.6-0.560.810.95-0.550.45-0.54-0.220.90.82-0.56-0.160.83-0.340.40.880.94
-0.020.11-0.13-0.16-0.05-0.17-0.17-0.18-0.080.01-0.19-0.58-0.22-0.04-0.190.07-0.14-0.21-0.080.31-0.64-0.04-0.08
0.90.110.720.720.89-0.84-0.84-0.810.720.98-0.810.17-0.81-0.30.830.87-0.77-0.20.86-0.420.250.910.79
0.83-0.130.721.00.95-0.3-0.3-0.250.990.79-0.240.54-0.260.10.950.71-0.22-0.230.84-0.310.710.730.94
0.84-0.160.721.00.95-0.3-0.3-0.250.980.79-0.250.54-0.260.090.960.71-0.24-0.210.84-0.310.720.740.94
0.9-0.050.890.950.95-0.59-0.59-0.540.940.92-0.530.43-0.55-0.050.980.83-0.5-0.210.92-0.380.580.860.92
-0.6-0.17-0.84-0.3-0.3-0.591.01.0-0.3-0.770.990.070.990.4-0.52-0.70.960.05-0.630.360.09-0.73-0.4
-0.6-0.17-0.84-0.3-0.3-0.591.01.0-0.3-0.770.990.070.990.4-0.52-0.70.960.05-0.630.370.09-0.73-0.4
-0.56-0.18-0.81-0.25-0.25-0.541.01.0-0.25-0.741.00.110.990.41-0.48-0.670.960.05-0.590.360.13-0.7-0.35
0.81-0.080.720.990.980.94-0.3-0.3-0.250.78-0.240.53-0.260.120.930.72-0.2-0.270.82-0.30.690.710.91
0.950.010.980.790.790.92-0.77-0.77-0.740.78-0.730.32-0.73-0.240.890.88-0.7-0.180.86-0.420.370.920.86
-0.55-0.19-0.81-0.24-0.25-0.530.990.991.0-0.24-0.730.130.990.4-0.47-0.650.960.04-0.580.330.14-0.68-0.35
0.45-0.580.170.540.540.430.070.070.110.530.320.130.130.150.560.240.090.030.29-0.240.60.230.57
-0.54-0.22-0.81-0.26-0.26-0.550.990.990.99-0.26-0.730.990.130.29-0.48-0.650.960.05-0.570.290.14-0.66-0.36
-0.22-0.04-0.30.10.09-0.050.40.40.410.12-0.240.40.150.290.02-0.280.390.02-0.250.50.17-0.380.0
0.9-0.190.830.950.960.98-0.52-0.52-0.480.930.89-0.470.56-0.480.020.76-0.46-0.110.87-0.340.630.80.95
0.820.070.870.710.710.83-0.7-0.7-0.670.720.88-0.650.24-0.65-0.280.76-0.63-0.390.91-0.520.420.940.69
-0.56-0.14-0.77-0.22-0.24-0.50.960.960.96-0.2-0.70.960.090.960.39-0.46-0.63-0.01-0.580.30.14-0.68-0.36
-0.16-0.21-0.2-0.23-0.21-0.210.050.050.05-0.27-0.180.040.030.050.02-0.11-0.39-0.01-0.20.55-0.06-0.14-0.1
0.83-0.080.860.840.840.92-0.63-0.63-0.590.820.86-0.580.29-0.57-0.250.870.91-0.58-0.2-0.430.580.950.79
-0.340.31-0.42-0.31-0.31-0.380.360.370.36-0.3-0.420.33-0.240.290.5-0.34-0.520.30.55-0.43-0.37-0.42-0.21
0.4-0.640.250.710.720.580.090.090.130.690.370.140.60.140.170.630.420.14-0.060.58-0.370.440.52
0.88-0.040.910.730.740.86-0.73-0.73-0.70.710.92-0.680.23-0.66-0.380.80.94-0.68-0.140.95-0.420.440.76
0.94-0.080.790.940.940.92-0.4-0.4-0.350.910.86-0.350.57-0.360.00.950.69-0.36-0.10.79-0.210.520.76
Click cells to compare fundamentals

Chromadex Corp Account Relationship Matchups

Chromadex Corp income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization1.5M1.5M1.6M1.9M1.7M863.7K
Interest Expense847K71K55K3K3.5K3.3K
Selling General Administrative34.3M30.4M36.4M28.3M25.0M16.5M
Total Revenue46.3M59.3M67.4M72.1M83.6M87.7M
Gross Profit25.8M35.3M41.5M42.8M50.8M53.3M
Other Operating Expenses77.6M79.1M94.5M90.7M89.2M93.6M
Operating Income(31.3M)(19.9M)(27.1M)(18.6M)(5.6M)(5.9M)
Ebit(31.3M)(19.9M)(27.1M)(18.6M)(5.6M)(5.9M)
Ebitda(29.8M)(18.3M)(25.4M)(16.7M)(3.9M)(4.1M)
Cost Of Revenue20.5M24.0M26.0M29.3M32.8M34.4M
Total Operating Expenses57.1M55.1M68.6M61.4M56.4M29.3M
Income Before Tax(32.1M)(19.9M)(27.1M)(16.5M)(4.9M)(5.2M)
Total Other Income Expense Net(847K)(71K)(55K)2.1M661K694.1K
Net Income(31.5M)(18.5M)(25.6M)(14.4M)(4.9M)(5.2M)
Income Tax Expense(676K)(1.4M)(1.6M)(2.1M)1.5M1.6M
Selling And Marketing Expenses18.2M20.9M28.4M28.3M26.4M27.8M
Research Development4.4M3.7M3.8M4.8M5.0M2.8M
Net Income From Continuing Ops(32.1M)(19.9M)(27.1M)(18.6M)(6.5M)(6.8M)
Net Income Applicable To Common Shares(32.1M)(19.9M)(27.1M)(16.5M)(14.9M)(15.6M)
Net Interest Income(847K)(71K)(55K)3K405K425.3K
Reconciled Depreciation1.5M1.5M1.6M1.9M1.8M1.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Chromadex Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chromadex Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chromadex Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chromadex Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chromadex Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For information on how to trade Chromadex Stock refer to our How to Trade Chromadex Stock guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chromadex Corp. If investors know Chromadex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chromadex Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.02
Revenue Per Share
1.215
Quarterly Revenue Growth
0.312
Return On Assets
0.0051
Return On Equity
0.0482
The market value of Chromadex Corp is measured differently than its book value, which is the value of Chromadex that is recorded on the company's balance sheet. Investors also form their own opinion of Chromadex Corp's value that differs from its market value or its book value, called intrinsic value, which is Chromadex Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chromadex Corp's market value can be influenced by many factors that don't directly affect Chromadex Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chromadex Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chromadex Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chromadex Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.